Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterNo recent work listed

Marsha L. Frazier

Matched on OpenAlex author ID A5112024668; NIH RePORTER profile ID 1967897. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 5)
Trials
0
Grants
1
Labs led
1
Collaborators
31
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: none · 2014: 3 papers · 2015: 2 papers, 1 grant · 2016: 1 paper · 2017: 1 paper

Papers 10

  1. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. Co-author DOI 10.1093/jnci/djw341↗
  2. Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets. Last author DOI 10.18632/oncotarget.10924↗
  3. Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival. Last author DOI 10.1097/mpa.0000000000000263↗
  4. Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. Co-author DOI 10.1371/journal.pone.0139049↗
  5. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Last author DOI 10.1002/mc.22023↗
  6. Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer. First author DOI 10.1007/s10620-013-2938-9↗
  7. Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer. Co-author DOI 10.7150/jca.10094↗
  8. A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians. Last author DOI 10.1002/mc.20808↗
  9. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Last author DOI 10.1097/mpa.0b013e318219dafe↗
  10. A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. Co-author DOI 10.1158/1940-6207.capr-10-0025↗

Grants 1

  1. Biomarkers for the Early Detection of Pancreatic Cancer U01CA111302↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Subrata Sen · 8 shared papers, 1 shared grant, 2011–2017 · strength 0.50
  2. Ann McNeill Killary · 8 shared papers, 1 shared grant, 2011–2017 · strength 0.50
  3. Randall E. Brand · 4 shared papers, 2015–2017 · strength 0.21
  4. Jinyun Chen · 5 shared papers, 2011–2016 · strength 0.20
  5. Chongjuan Wei · 3 shared papers, 2012–2014 · strength 0.13
  6. Seetharaman Balasenthil · 3 shared papers, 2011–2017 · strength 0.12
  7. Sudhir Srivastava · 2 shared papers, 2015–2017 · strength 0.10
  8. Ying Huang · 2 shared papers, 2015–2017 · strength 0.10
  9. Xifeng Wu · 2 shared papers, 2011–2016 · strength 0.09
  10. Wei Chen · 1 shared paper, 2016 · strength 0.06
  11. Suyu Liu · 1 shared paper, 2017 · strength 0.06
  12. Jill Palmer Smith · 1 shared paper, 2015 · strength 0.06
  13. Gail L. Matters · 1 shared paper, 2015 · strength 0.06
  14. David Clement Whitcomb · 1 shared paper, 2015 · strength 0.06
  15. Yu-Jing Huang · 1 shared paper, 2014 · strength 0.06
  16. Qian Liu · 1 shared paper, 2014 · strength 0.04
  17. Jin Wang · 1 shared paper, 2014 · strength 0.04
  18. Jin Wang · 1 shared paper, 2014 · strength 0.04
  19. Xiaoqun Dong · 1 shared paper, 2014 · strength 0.04
  20. Sushovan Guha · 1 shared paper, 2014 · strength 0.04
  21. Michael B. Wallace · 1 shared paper, 2014 · strength 0.04
  22. Massimo Raimondo · 1 shared paper, 2014 · strength 0.04
  23. Herbert J. Zeh · 1 shared paper, 2015 · strength 0.04
  24. Peter J. Allen · 1 shared paper, 2015 · strength 0.04
  25. Michael Anthony Hollingsworth · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.